BioCentury
ARTICLE | Financial News

Days after first drug approval, Rigel raises $62.4M

April 20, 2018 2:45 PM UTC

Rigel Pharmaceuticals Inc. (NASDAQ:RIGL) raised $62.4 million through the sale of 16 million shares at $3.90 in a follow-on underwritten by Jefferies, Piper Jaffray, BMO Capital Markets and H.C. Wainwright.

The price is a tiny premium to Rigel's closing price of $3.88 on Wednesday, when it proposed after market hours to sell 15 million shares. Rigel added $0.18 to $4.06 on Thursday and then priced the offering after market close. Its shares were off $0.22 to $3.84 on Friday...